ADAMTS-17 Antibodies

Santa Cruz Biotechnology features a diverse variety of ADAMTS-17 monoclonal antibodies for research focused on understanding this important metalloproteinase. Multiple applications are supported, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). ADAMTS-17, a member of the ADAMTS (A Disintegrin and Metalloproteinase with Thrombospondin Motifs) family, plays a crucial role in the processing of extracellular matrix components, particularly in the degradation of aggrecan, a key proteoglycan in cartilage. ADAMTS-17 is significant in various physiological and pathological processes, including tissue remodeling and the development of osteoarthritis. Understanding ADAMTS-17 function is essential for elucidating its contributions to connective tissue disorders and potential therapeutic targets. Researchers can explore ADAMTS-17 expression patterns across different tissues and cellular compartments. Advanced detection methods using horseradish peroxidase (HRP), phycoerythrin (PE), and fluorescein isothiocyanate (FITC) conjugates enable versatile experimental approaches. Santa Cruz Biotechnology monoclonal antibodies for ADAMTS-17 support researchers worldwide in advancing our understanding of tissue development and disease mechanisms.